Standard of Care vs. FDA Approved – How We Choose a Treatment
Avastin® is not FDA (Food and Drug Administration) approved for treating wet macular degeneration, but it is the standard of care for treating the disease. The FDA has given approval for Avastin to...
View ArticleAvastin and Lucentis: Neck and Neck
Both Avastin and Lucentis are anti-VEGF treatments for wet macular degeneration. Both are manufactured by Genentech (Roche). A small study just published found no clinical difference between the two...
View ArticleAvastin Versus Lucentis; And the Winner Is…
Both Avastin and Lucentis are anti-VEGF treatments for wet macular degeneration. Both are manufactured by Genentech (Roche). A small study just (February 2010, Ophthalmology) published found no...
View ArticleNew Treatment for Diabetic Eye Disease
A combination of intravitreal injection of Lucentis (ranibizumab) plus laser has just been proven to be a new and more effective treatment for diabetic macular edema. For the past 25 years, laser...
View ArticleRetinal Ischemia: Supply vs. Demand
Retinal ischemia causes VEGF to be liberated inside the eye. In cases of diabetes this can lead to diabetic retinal detachment or neovascular glaucoma. Treatments included pan-retinal...
View ArticleCombination Injections for Diabetic Retinopathy
Injecting both Avastin and a steroid injection can be a useful way to treat stubborn macular edema from diabetic retinopathy. While both can be used alone to treat macular swelling in diabetic...
View ArticleLaser and anti-VEGF Best Treats Diabetic Macular Edema
Treating diabetic retinopathy with both laser and anti-VEGF injections may be the best way to treat patients with diabetic macular edema. Diabetic macular edema is the most common “side effect” of...
View ArticleAvastin and Lucentis Are Equally Safe, Too.
The results of the CATT trial demonstrated that Avastin and Lucentis are equally effective for the treatment of wet macular degeneration. A small issue, since the release of that data, appears to...
View ArticleLucentis Approved for Diabetic Retinopathy
Lucentis is now FDA approved for the treatment of diabetic macular edema (DME). Diabetic macular edema is the most common “complication” of diabetic retinopathy. Retinal swelling can now be treated by...
View ArticleEylea Best for Diabetic Macular Edema | Treatment for DME
Eylea, Lucentis and Avastin were compared head to head for the treatment of diabetic macular edema. For certain patients with this common complication of diabetic retinopathy, Eylea was superior....
View Article